LDN Pharmacogenenomics
Low-Dose Naltrexone and Pharmacogenomics:How Your Genes Shape Your Response to LDN
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Low-dose naltrexone (LDN) has become one of the most versatile tools in integrative medicine, with applications spanning autoimmune disease, chronic pain, fibromyalgia, and neuroinflammation. Yet clinicians who prescribe LDN frequently observe a puzzling pattern: